The mission of CCRA’s Advisory Board is to identify strategic priorities for cancer research funding, monitor the investment in cancer research, reinforce the value of research, and strengthen the cancer research community through the support of core activities and research partnerships.
In addition to the roles and responsibilities of members, representatives to the Advisory Board:
- identify emerging priorities for consideration and/or action
- advise the Secretariat on core activities
- facilitate dissemination of CCRA activities and reports
- participate in CCRA awards adjudication
- engage in partnerships/collaborations with other members as appropriate
- determine appropriate policies for CCRA (i.e., website posts, outreach, CCRA logo use)
Advisory Board Composition
The CCRA Advisory Board is comprised of prescribed, elected, and appointed members as follows:
Prescribed
- 3 representatives from among the member Federal government organizations with the highest investments in cancer research
- 3 representatives from among the Provincial government organizations with the highest investments in cancer research
- 3 representatives from among the charitable organizations/associations with the highest investments in cancer research
- 1 representative from the Canadian Partnership Against Cancer (CPAC)
- 1 representative from the Canadian Association of Provincial Cancer Agencies (CAPCA)
Elected
- 2 members nominated from among the broad membership
Appointed
- 3 patient/family representatives from among participants of the Patient Involvement in Cancer Research Program (PIP), representing different jurisdictions in Canada